Hypothalamic-pituitary-adrenal function in patients receiving intermittent high dose prednisone therapy for lymphoma.
D000324:Adrenocorticotropic Hormone; D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D006689:Hodgkin Disease / Q000188:drug therapy; D006801:Humans; D007030:Hypothalamo-Hypophyseal System / Q000503:physiopathology*; D008223:Lymphoma / Q000188:drug therapy*; D008875:Middle Aged; D010913:Pituitary-Adrenal System / Q000503:physiopathology*; D011241:Prednisone / Q000008:administration & dosage*; D011725:Pyridines
D011725:Pyridines; C013109:metapyrone; D000324:Adrenocorticotropic Hormone; D011241:Prednisone